r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AG

Alastair Garfield

Insider · Chief Scientific Officer · RYTM

Alastair Garfield files insider transactions with the SEC as a chief scientific officer of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 10 July 2024, 1 of them in the last 90 days.

  • Files forRYTM
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure17 August 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 8 July 2024 — 13 August 2026Chief Scientific Officer · Rhythm Pharmaceuticals (RYTM)25 Form 4 lines · source: SEC Form 4

Everything they disclosed

25 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.